|
Calcium arsenate (as As) |
CAS 7778-44-1 | ||
Ca3(AsO4)2 |
RTECS CG0830000 | ||
Synonyms & Trade Names Calcium salt (2:3) of arsenic acid, Cucumber dust, Tricalcium arsenate, Tricalcium ortho-arsenate [Note: Also see specific listing for Arsenic (inorganic compounds, as As).] |
DOT ID & Guide 1573 151 |
Exposure
|
NIOSH REL: Ca C 0.002 mg/m3 [15-minute] See Appendix A | ||
OSHA PEL: [1910.1018] TWA 0.010 mg/m3 | |||
IDLH Ca [5 mg/m3 (as As)] See: 7778441 | Conversion |
Physical Description Colorless to white, odorless solid. [insecticide/herbicide] |
|||
MW: 398.1 |
BP: Decomposes |
MLT: ? |
Sol(77°F): 0.01% |
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 3.62 |
Fl.P: NA |
UEL: NA |
LEL: NA |
|
Noncombustible Solid | |||
Incompatibilities & Reactivities None reported [Note: Produces toxic fumes of arsenic when heated to decomposition.] |
Measurement Methods NIOSH 7900; OSHA ID105 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Lassitude (weakness, exhaustion); gastrointestinal disturbance; peripheral neuropathy; skin hyperpigmentation, palmar planter hyperkeratoses; dermatitis; [potential occupational carcinogen]; in animals: liver damage | |
Target Organs
Eyes, respiratory system, liver, skin, central nervous system, lymphatic system Cancer Site [lymphatic & lung cancer] |
See also: INTRODUCTION See ICSC CARD: 0765 |